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Neutrophils
HL-60 cells(Ap), the etiologic agent of the tick-borne disease human granulocytic
anaplasmosis, is an obligate intracellular pathogen unique in its ability to target and replicate within
neutrophils. We deﬁne and compare the spectra of host gene expression in response to Ap infection of
human neutrophils and of HL-60 cells using long (70-mer)-oligonucleotide array technology. In addition to
apoptosis-related genes, genes involved in signaling pathways, transcriptional regulation, immune response,
host defense, cell adhesion, and cytoskeleton were modulated in neutrophils infected with Ap. Ap infection
affected the same pathways in HL-60 cells but transcriptional changes occurred more slowly and in a reduced
spectrum of genes. Gene expression changes detected by microarray were conﬁrmed for randomly selected
genes by QRT-PCR and Western blot studies. These studies demonstrate for the ﬁrst time that the ERK
pathway is activated in Ap-infected neutrophils and also deﬁne multiple pathways that are activated during
intracellular Ap infection, which together serve to prolong the cell survival that is needed to allow bacterial
replication and survival in neutrophils, which otherwise would rapidly apoptose.
Published by Elsevier Inc.Human granulocytic anaplasmosis is an emerging tick-borne
zoonosis caused by Anaplasma phagocytophilum (Ap), an obligate
gram-negative intracellular pathogen unique in its ability to target
and replicate within granulocytes [1,2]. Ap replicates within vacuoles
to form microcolonies (morulae) that do not fuse with lysosomes [3].
Ap naturally infects human neutrophils and their progenitors and also
infects cell lines (e.g., HL-60 and NB4) that express α-(1,3) fucosylated
PSGL-1 on their surface [4]. The avidity of Ap for α-(1,3) fucosylated
PSGL-1 is likely important in its tropism for phagocytes, which richly
express this glycosylated molecule on their surface [4,5]. Recent
studies have demonstrated that Ap can use alternate receptors, for
example, infecting cultured vascular endothelial cells [6], which do
not express PSGL-1. The tropism of this organism for neutrophils and
its ability to evade highly toxic phagocytic pathways predict that the
organism has evolved unique strategies for intraphagocytic survival
and replication.
Neutrophils normally undergo rapid spontaneous apoptosis both
in vitro and in vivo [7,8]. Ap infection delays normal neutrophil
apoptosis in a dose-dependent manner facilitating its intracellular
replication and survival [7–9]. Primary neutrophils are short-lived anddman).
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nc.challenging to study in vitro. Myeloid cell lines can provide alternative
models for Ap infection. HL-60 is a promyelocytic leukemia-derived
cell line used to grow Ap. HL-60 cells retain many characteristics of
human leukocyte progenitors, including the potential to undergo
partial differentiation into morphologically mature neutrophils [10].
However, HL-60 cells lack formyl-Met-Leu-Phe and interleukin (IL-8)-
induced chemotaxis [11], and IL-8 is upregulated during Ap infection
[12] and is an important neutrophil recruitment chemokine for Ap
survival [13]. Also, unlike neutrophils, HL-60 cells are immortal and do
not rapidly and spontaneously undergo apoptosis [2]. Despite such
differences, HL-60 cells have been very useful in dissecting the
molecular and cellular biology of Ap infection. However, given major
differences between these transformed cells and primary granulocytic
cells and precursors in the living host, it is important to examine
events and, wherever possible, evaluate major ﬁndings in primary
cells. In addition, cell-type-speciﬁc differences in the host–pathogen
interaction may reﬂect important biologic strategies of the pathogen.
Therefore we undertook a comparative high-throughput assessment
of Ap-induced transcriptional responses in neutrophils and HL-60
cells.
We used human long (70-mer)-oligonucleotide array chips con-
taining approximately 17,000 probes to perform gene expression
proﬁling of human neutrophils and HL-60 cells at various time points
after high-multiplicity Ap infection. Our results provide comprehen-
sive new data and insights into delayed apoptosis, infection-induced
signaling pathways, transcriptional regulation, immune response, and
Table 1
Upregulated neutrophil genes after 1, 3, and 8 h of Ap infectiona
Gene 1 hb 3 hb 8 hc
Apoptosis/cell fate
NFKBIA* 4.1 4.2 1.7
BCL2A1* 2.8 8.6 3.2
GADD45B* 2.3 7.7 4.1
SOD2* 2.8 6.2 11.7
TNFAIP3* 4.6 2.1 —
IER3 3.0 3.5 5.9
HIF1A 1.7 4.3 3.9
AXUD1 3.0 3.0 1.2
MAP2K3 1.8 3.2 1.4
STAT5A 1.6 3.5 2.1
CD44* 1.6 3.1 2.1
CDKN1A 1.3 3.0 6.0
BIRC3* 2.2 2.2 —
PPP1R15A* 2.5 2.6 —
BCL3* 2.0 2.3 —
CD14 1.5 2.2 2.7
CFLAR 1.6 2.5 6.1
BID 1.3 2.1 4.1
Cytokines/chemokines and their receptors
CCL3* 8.9 24.3 23.9
CCL3L3 8.1 17.0 15.8
IL8* 2.8 15.0 6.2
IL1B* 10.4 10.1 1.8
CCL4* 2.7 6.7 4.7
IL1RN* 2.7 4.2 —
CXCL1* 5.4 4.6 2.7
CXCR4 2.7 3.3 6.0
PBEF1 2.0 4.4 —
OSM 3.9 1.3 1.3
TNF — 3.6 1.3
GPR109B 2.6 2.6 6.9
GK001 2.6 2.5 4.0
Calcium ion binding
S100P 2.0 2.7 1.1
NOTCH2NL 1.8 3.0 3.2
Cell adhesion and cytoskeleton
TNFAIP6* 2.0 2.8 17.3
TMSB4X 2.6 4.4 6.4
MARCKS* 1.4 3.8 2.9
ICAM1* 1.4 2.8 1.3
PFN1 2.4 4.2 4.1
FGR 1.7 3.2 7.0
ACTB 2.2 3.0 2.4
MID1IP1 2.8 2.9 2.0
LCP1 1.9 2.1 3.4
GABARAPL2 1.5 2.9 7.1
RHOF 0.8 2.3 3.4
Immune response/host defense
PI3 (SKALP) 2.4 11.4 23.9
CD83* 2.5 9.5 —
LCP2 (SLP-76) 2.8 5.7 4.0
SERPINB1 1.8 4.6 1.4
IGSF6 1.8 3.8 5.0
PRG1 1.8 2.9 4.8
Transcriptional regulation
ZC3H12A 2.6 9.2 5.4
NFKBIE* 2.2 3.1 3.1
ZNF267 1.5 2.5 2.9
ZNF117 2.4 3.1 4.2
ZFP36 3.6 3.2 4.0
JUNB 3.3 3.7 7.2
NFKB1(p105)* 1.1 4.5 4.2
HDGF 1.5 3.4 6.5
ATF5 2.5 2.7 3.7
NFKB2* 1.9 2.9 1.7
HDAC6 1.8 2.6 4.1
TANK* 1.1 2.0 5.2
RBBP7 3.6 1.1 —
ID2 1.3 3.0 2.3
(continued on next page)
Table 1 (continued)
Gene 1 hb 3 hb 8 hc
Zinc ion binding
SQSTM1 2.1 3.8 5.6
ADAM8 1.9 2.4 5.8
Transporters
CLIC4 1.1 3.1 2.8
SLC15A3 1.6 2.6 1.0
ATP6V1B2 1.9 2.4 6.7
ATP6V0D1 1.8 2.4 2.3
Metabolism/enzymes
B4GALT5* 1.5 6.9 1.5
PFKFB3 3.3 1.9 2.9
ACSL1 1.6 2.7 1.7
AICDA 2.6 3.0 2.6
Signaling molecules
PLAU* 3.9 19.6 2.1
DUSP2* 3.5 2.8 3.0
PLEK 2.8 4.7 6.5
RASGRF1 1.6 3.6 1.4
DUSP1 3.9 4.4 1.7
PIM2 2.1 3.7 2.8
PRKCD 1.7 3.7 2.0
GPR84* 1.2 2.5 1.7
TNIP1 1.1 2.7 1.8
PDE4B 1.9 2.7 2.4
VEGF* 2.0 2.3 2.1
GRIPAP1 1.9 3.0 2.8
ADORA2A 1.5 2.8 —
SPHK1 1.8 2.5 1.8
RAB6IP1 1.3 2.9 2.7
Miscellaneous
EHD1* 2.0 3.7 —
FTHL12 2.4 3.2 5.8
TNFAIP2 2.0 3.0 1.1
SELK 2.6 2.6 1.6
HNRPC 1.3 3.1 2.3
KIAA0247 1.8 2.5 1.8
Hypothetical gene mRNA* (LOC65309) 2.0 3.5 4.8
a Genes included are twofold or greater upregulated at 3 h. Fold change greater than
3 has a conﬁdence interval of 99%. Fold change greater than 2 has a conﬁdence interval
of 90%.
b The mean of three biological repeats with similar general fold increase is presented
for 1 and 3 h.
c Data for 8 h are from a single microarray experiment.
* Genes were also identiﬁed by Sukumaran et al. [24].
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and cytoskeleton molecules in Ap-infected neutrophils and HL-60
cells. In addition, we demonstrate for the ﬁrst time that the ERK
pathway is activated in human neutrophils as a result of Ap infection.
Results
Alterations of neutrophil and HL-60 gene expression proﬁles by Ap
infection
Puriﬁed human neutrophils and HL-60 cells were infected with
Ap- or mock-infected inocula and sampled at different postinfection
time points (1, 3, and 8 h for infected neutrophils and 2, 8, and 22 h for
infected HL-60 cells). Total RNAs were isolated from samples for
microarray experiments. RNAs from mock-infected neutrophils and
HL-60 cells, as appropriate, served as reference controls in experi-
ments. Ninety-six genes were found to be reproducibly upregulated at
least twofold within 3 h of Ap infection of neutrophils (Table 1). The
most highly upregulated transcripts early postinfection included
genes for cytokines/chemokines and their receptors (e.g., CCL3,
CCL3L3, IL8, IL1β, and CXCR4), genes related to apoptosis and the
immune response (e.g., BCL2A1, SOD2, IER3, PI3, CD83, and LCP2),
Table 2
HL60 genes upregulated by A. phagocytophiluma
Gene symbol Accession No. Fold increase Protein or gene
2 hb 8 hc 22 hd
IL1B* NM_000576 6.3 3.8 2.7 Interleukin 1β
CCL3* NM_001034082 4.4 3.0 2.5 Chemokine (C-C motif) ligand 3
PDE4B* NM_002600 3.7 1.7 1.1 Phosphodiesterase 4B, cAMP-speciﬁc
NFKBIA* (IKBA) NM_020529 3.2 3.6 2.9 Nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor, α (MAD3)
IL8* NM_000584 3.2 3.3 2.2 Interleukin 8
TNFAIP2* NM_006291 3.1 4.5 2.9 Tumor necrosis factor, α-induced protein 2
TNFAIP3* NM_006290 3.0 4.1 2.2 Tumor necrosis factor, α-induced protein 3
CCL4* NM_002984 2.9 2.4 1.3 Chemokine (C-C motif) ligand 4
CD83* NM_004233 2.8 2.8 2.2 CD83 antigen (activated B lymphocytes, immunoglobulin superfamily)
CCL3L3* NM_001001437 2.6 2.8 1.4 Chemokine (C-C motif) ligand 3-like 3
RABGAP1L NM_014857 2.6 — — RAB GTPase-activating protein 1-like
NBPF15 NM_173638 2.6 1.4 1.9 Neuroblastoma breakpoint family, member 15
C4orf19 NM_018302 2.5 −1.6 −1.6 Chromosome 4 open reading frame 19
DUSP2* NM_004418 2.4 1.9 1.1 Dual-speciﬁcity phosphatase 2 (DUSP2)
PPP1R15A* (GADD34) NM_014330 2.4 1.6 1.6 Protein phosphatase 1, regulatory (inhibitor) subunit 15A (GADD34)
CFHR4 NM_006684 2.3 2.0 1.9 Complement factor H-related 4
BCL3* NM_005178 2.3 2.7 2.3 B cell CLL/lymphoma 3
TNF* NM_000594 2.2 1.3 1.2 Tumor necrosis factor (TNF superfamily, member 2; TNF-α)
AR NM_000044 2.2 1.5 1.8 Androgen receptor, transcript variant 2
NBPF14 NM_015383 2.1 2.4 1.8 Neuroblastoma breakpoint family, member 14
NFKBIE* (IKBE) NM_004556 2.1 1.8 -1.3 Nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor, ɛ
CYLD NM_015247 2.1 1.0 -1.7 Cylindromatosis (turban tumor syndrome)
ZC3H12A* NM_025079 2.1 2.2 1.1 Zinc ﬁnger CCCH-type containing 12A
SQSTM1* NM_003900 2.0 1.9 1.7 Sequestosome 1
CCL14 NM_032963 2.0 1.3 1.3 Chemokine (C-C motif) ligand 14
NCOA7 NM_181782 2.0 1.5 1.1 Nuclear receptor coactivator 7
TNFAIP6* NM_007115 2.0 2.2 1.0 Tumor necrosis factor, α-induced protein 6
a Genes included are twofold or greater upregulated at 2 h and are listed in order of level of increase at 2 h. Fold change greater than 3 has a conﬁdence interval of 99%.
b Means of four biological repeats with similar general fold increase are presented.
c Means of two biological repeats with similar general fold increase are presented.
d Data are from a single microarray experiment.
⁎ Genes also found upregulated twofold or greater in Ap-infected neutrophils at 3 h.
Table 3B
HL-60 genes signiﬁcantly downregulated by A. phagocytophilum infection
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ZC3H12A, and NFKB1), and genes related to cell adhesion and to the
cytoskeleton (e.g., TMSB4X, MARCKS, and PFN1). Some of these genes
maintained high levels of expression for at least 8 h following Ap
infection (e.g., SOD2, IER3, CCL3, CCL3L3, CXCR4, TMSB4X, and PI3). In
contrast, only a few neutrophil genes were signiﬁcantly down-
regulated by Ap infection (Table 3A). Interestingly, these included
the proapoptotic genes CARD10, TAIP-2, and SMAD7. Because mock-
infected neutrophils underwent rapid spontaneous apoptosis, a
suitable control was not available and differential gene expression
proﬁling later than 8 h after infection was not performed in
neutrophils but was investigated in HL-60 cells.Table 3A
Neutrophil genes signiﬁcantly downregulated by A. phagocytophilum infection
Gene 1 ha 3 ha 8 ha
FRAT1 −3.8 2.1 —
MPO −2.2 −1.1 1.3
ADPRH −2.1 −1.4 1.0
ELP4 — −4.0 —
CARD10 −1.1 −2.4 —
TAIP-2 −1.1 −2.4 1.1
ATP2B3 1.0 −2.2 —
SMAD7 1.3 −2.0 —
FGF1 1.1 −1.5 −3.3
PPARD 1.0 −1.1 −3.0
TF 1.0 −1.3 −2.6
PCSK4 −1.2 −1.1 −2.6
THOC2 −1.1 −1.3 −2.3
IDUA 1.0 −1.3 −2.1
MUC12 1.0 −1.3 −2.1
TEX2 −1.3 −1.1 −2.0
Bold numbers indicate down regulation of genes by at least 2 fold.
a Fold decrease compared to uninfected control.HL-60 cells were infected with Ap or mock infected and sampled
2, 8, or 22 h after infection and subjected to microarray hybridization
and analysis. Twenty-seven genes were found to be reproducibly
upregulated at least twofold within 2 h of Ap infection of HL-60
(Table 2). The number of upregulated HL-60 genes increased to 52
after 8 h and decreased again to 35 at 22 h following Ap infection
(Table 4). Not only were fewer genes upregulated, but the host cell
transcriptional response to Ap infectionwas generally slower and lessGene 2 ha 8 ha 22 ha
TXNDC12 −5.3 — —
PLEKHA4 −4.5 1.2 −1.3
ZNF250 −3.4 — −1.3
NHEJ1 −3.1 — —
KLRC3 −3.0 — —
HARSL 1.0 −3.3 —
CITED2 1.1 −3.2 —
CD5L 1.1 −3.0 −1.1
C14orf105 −1.2 −2.8 —
ELA2 −1.2 −1.5 −4.5
PARP1 1.0 −1.6 −4.5
PIK3CB 1.1 1.0 −4.0
RAD23 1.1 −1.5 −3.7
ANKRD15 −1.3 −1.5 −3.7
CLPP 1.0 −1.6 −3.6
A4GALT 1.0 −1.6 −3.6
PRO0618 −1.2 −1.2 −3.4
HYPK 1.0 −1.5 −3.3
PRNP 1.1 −1.3 −3.0
CAPN1 −1.3 −1.4 −3.0
TNFRSF1A −1.2 −1.6 −2.9
Bold numbers indicate down regulation of genes by at least 2 fold.
a Fold decrease compared to uninfected control.
Table 4
HL-60 genes that are more than twofold upregulated after 8 or 22 h A. phagocytophilum
infection
8 h 22 h
Gene Fold increase Gene Fold increase
CCL1 4.7 NCF1 3.9
BIRC3 4.5 C3 3.2
TNFAIP2 4.5 BIRC3 2.9
RBM10 4.4 NFKBIA 2.9
NFKB2 4.3 TNFAIP2 2.9
TNFAIP3 4.1 NFKBIA 2.7
IL1B 3.8 IL1B 2.7
NFKBIA 3.8 NUSAP1 2.6
PSTPIP2 3.6 FMNL3 2.6
NFKBIA 3.6 CCL3 2.5
TPD52L1 3.5 LGALS1 2.5
IL8 3.3 CD48 2.5
PSTPIP2 3.2 FAM111A 2.5
CCL3 3.0 KCNAB2 2.4
IQWD1 2.9 TMED9 2.4
TMEM76 2.8 SLC8A2 2.4
FUSIP1 2.8 IL23A 2.4
NFKB1 2.8 CCND3 2.3
CD83 2.8 MYBL2 2.3
CCL3L3 2.8 VPS45A 2.3
FLJ12190 2.7 AP1M1 2.3
GGT1 2.7 ARPC1B 2.3
HSPA8 2.7 BCL3 2.3
BICD2 2.7 TYR 2.3
BCL3 2.7 PRO2958 2.3
ZDHHC18 2.7 ZMAT3 2.3
NXF5 2.6 CCNJ 2.3
RELB 2.6 C6orf157 2.3
CYLD 2.5 NUCB1 2.3
SIAH2 2.5 NXF5 2.2
DHDDS 2.4 TNFAIP3 2.2
CCL4 2.4 FADS2 2.2
NBPF14 2.4 ACTL6B 2.2
PTGS1 2.4 CD83 2.2
ADRM1 2.4 TACC3 2.2
PSMD14 2.4
PX19 2.4
GGT2 2.4
PDF 2.4
ZNF20 2.3
CR1 2.3
TMEM165 2.3
DMXL2 2.3
MRPS18B 2.3
WNT3 2.3
SLC39A1 2.3
RPL19 2.3
PTTG1 2.3
ZC3H12A 2.2
TMEM132C 2.2
UBADC1 2.2
NPHP1 2.2
Table 5
Quantitative real-time RT-PCR conﬁrmation of genes in neutrophil after 3 h Ap infection
Gene
name
Primer sequences (5′ to 3′) Size of
amplicon
(bp)
Fold increasea
Microarray QRT-PCR
CCL3 Forward: TGCTTCAGCTACACCTCC 108 24.3 52.9
Reverse: GCTTCGCTTGGTTAGGA
PI3 Forward: CTTGATCGTGGTGGTGTT 126 11.4 17.3
(SKALP) Reverse: TTAACGGGATCTTGTCCA
PLAU Forward: AGTCACCACCAAAATGCTAT 118 19.6 59.9
Reverse: AATTCCAGTCAAAGTCATGC
ZC3H12A Forward:
TCCTGCGTAAGAAGCCACTCACTT
94 9.2 11.2
Reverse:
TGGAAGAATCGGCACTTGATCCCA
B4GALT5 Forward:
TTCATGATGCAAGCCCAAGGCA
95 6.9 17.1
Reverse: TTGGCATAAGCACTCCGAAGCA
CD83 Forward:
TGGGTCAAGTTATTGGAGGGTGGT
157 9.5 61.4
Reverse:
TGCAGCTGGTAGTGTTTCGGATCT
IL8RB Forward:
TGAGCCCATGGCACTCTATGTTCT
193 −2.3 −3.2
Reverse:
TGTGATTACAGGCACTCACCACCA
ACTB Forward: GGACTTCGAGCAAGAGATGG 234 3.0 2.5
Reverse: AGCACTGTGTTGGCGTACAG
GAPD Forward: AAGGTGAAGGTCGGAGTC 112 No
change
No
changeReverse: GGTCAATGAAGGGGTCAT
a Mean of three repeats comparing samples of Ap-infected and mock-infected PMNs
after 3 h incubation.
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and 2). As observed in neutrophils (1 h postinfection), genes that
were upregulated in HL-60 cells early after Ap infection (2 h)
included cytokines/chemokines and genes related to the immune
response (e.g., IL1β, CCL3, CCL4, IL8, and CD83), whereas genes
related to apoptosis and the Toll-like receptor signaling pathway (e.g.,
BIRC3, NFKB2, IL1β, NFKBIA, NFKB1, and CSF2RB) were ﬁrst found to
be upregulated 8 h postinfection. At 22 h postinfection, genes related
to host defense and innate immunity (e.g., NCF1, C3, CD48, and
LGALS1) as well as focal adhesion pathways (e.g., CCND3, GRB2, and
ACTC1) and genes related to the cytoskeleton, especially actin
(ARPC1B and CAPG), were among the upregulated genes of special
interest (Table 4).
Similar to the ﬁndings in neutrophils, a more limited number of
genes was downregulated in Ap-infected HL-60 cells (Table 3B). Theseincluded apoptosis-related genes, such as TNFRSF1A, CAPN1, and
PIK3CB (Table 3B). TNFRSF1A is a member of the TNF-receptor
superfamily that activates NF-κB and mediates apoptosis [14]. CAPN1
(calpain 1) is a calcium-activated, nonlysosomal, intracellular cysteine
protease that regulates Bax and subsequent Smac-dependent caspase-
3 activation in neutrophil apoptosis [15]. PIK3CB, encoding the
110-kDa catalytic subunit of the phosphoinositide 3-kinase complex,
is correlated with oncogenicity, survival, and antiapoptosis [16].
ELA2 was downregulated in Ap-infected HL-60 cells (Table 3B).
ELA2 encodes human neutrophil elastase 2, which is a serine protease
that hydrolyzes many proteins in addition to elastin. Following release
from activated neutrophils ELA2 hydrolyzes proteins within specia-
lized neutrophil lysosomes, the azurophil granules, as well as proteins
of the extracellular matrix. Interestingly, ELA2 degrades the outer
membrane protein A of Escherichia coli as well as the virulence factors
of such bacteria as Shigella, Salmonella, and Yersinia. Ap-induced
reduction in the expression of ELA2 may be important in increasing
bacterial survival inside host cells [17,18].
A comprehensive description of neutrophil and HL-60 genes that
are up- and downregulated by Ap infection is provided in Supple-
mentary Tables 1S and 2S.
Validation of microarray results by QRT-PCR analysis
To conﬁrm that gene expression results by microarray are rep-
resentative of actual transcriptional events, QRT-PCR analysis was also
performed using total RNA from mock- and Ap-infected neutrophils
obtained 3 h postinfection. We randomly selected seven upregulated
genes and one downregulated gene (upregulated, CCL3, PI3, PLAU,
ZC3H12A, B4GALT5, CD83, ACTB; downregulated, IL8RB). As shown in
Table 5, the results obtained via QRT-PCR are consistent with the
microarray ﬁndings. As expected, a higher degree of upregulation for
several genes was found when quantitatively determined by QRT-PCR
analysis compared to microarray quantitation.
Fig. 1. A. phagocytophilum-induced phosphorylation of ERK2 (p42) and increased
phosphorylation of p38MAPK in human neutrophils. Mock- (M) or Ap-infected (A)
neutrophils (1.5×107/ml) were harvested 1 or 3 h after infection. Equal amounts of cell
lysates (equivalent to 3×106 cells/lane) were subjected to gel electrophoresis and
Western blot analyses. The membrane was reacted with anti-phosphorylated ERK
(p-ERK) and anti-phosphorylated p38 MAPK (p-p38MAPK) polyclonal Ab overnight at
4 °C to detect phosphorylated ERK or p38MAPK. Ten microliters of bacterially expressed
ERK phosphorylated by MEK served as a phosphorylated-ERK positive control (C).
Immunoreactive signal was detected as described under Materials and methods. After
being stripped, the membrane was incubated with anti-ERK or anti-p38 MAPK Abs for
detection of total ERK or p38MAPK, respectively.
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infection
Our previous studies showed that Ap upmodulated multiple
signaling pathways to which ERK and p38MAPK belong [19]. In
addition, Choi et al. [20] demonstrated that p38MAPK was phos-
phorylated in response to Ap infection of neutrophils. To study
activation of signaling pathways by Ap, we performed Western blot
studies 1 and 3 h after Ap infection. Equal amounts of cell lysates from
mock- or Ap-infected neutrophils were subjected to gel electrophor-
esis and immunoblotting with an anti-phosphorylated ERK antibody,
which recognizes both phosphorylated ERK1 (p44) and ERK2 (p42),
and an anti-phosphorylated p38MAPK polyclonal antibody. As shown
in Fig.1, phosphorylation of ERK2 (p42) but not ERK1 (p44) was clearly
induced in neutrophils 3 h after Ap infection. In contrast, p38MAPK
was constitutively phosphorylated in mock-infected neutrophils and
was slightly increased at 1 and 3 h after Ap infection. This increasewas
more evident 3 h postinfection due to the decrease in constitutive
phosphorylation at 3 h relative to 1 h. These results demonstrate that
Ap activates host neutrophil ERK and p38MAPK pathways.
Discussion
Recent studies indicate that gene expression patterns in Ap-
infected neutrophils can provide a window into understanding
processes that permit the pathogen to subvert important host cell
functions. Several investigators have used microarray technology to
measure changes in cellular gene expression proﬁles following Ap
infection [21–24]. In this study, we provide a comprehensive
description of early transcriptional changes induced both in human
neutrophils, natural targets of infection, and in HL-60 cells (the most
commonly utilized cell line for studies of Ap) in response to efﬁcient
infection with Ap. Our results demonstrate that Ap rapidly modulates
host genes related to apoptosis, signaling pathways, transcriptional
regulation, immune response, and host defense, as well as genes
important in cell adhesion and in the cytoskeleton. These results
provide new information that supports and extends both our previous
study, in which we deﬁned early molecular events involved in Ap-
induced neutrophil antiapoptosis, and reports from other laboratories
proﬁling Ap-induced gene expression changes. Our studies provide atemporal analysis, including in natural host cells, allowing for a
comprehensive and comparative analysis of biologically relevant gene
expression changes.
Alteration of neutrophil gene expression induced by Ap infection
Among the genes that are most upregulated in the early
transcriptional response to infection in neutrophils are cytokines,
chemokines, and their receptors (e.g., CCL3, CCL3L3, IL8, IL1β, and
CXCR4); genes related to apoptosis and the immune response (e.g.,
BCL2A1, SOD2, IER3, PI3, CD83, and LCP2); signaling molecules and
transcription regulators (e.g., PLAU, PLEK, ZC3H12A, and NFKB1); and
genes related to cell adhesion and the cytoskeleton (e.g., TMSB4X,
MARCKS, and PFN1). Some of these genes sustained Ap-induced high
expression 8 h after infection (e.g., SOD2, IER3, CCL3, CCL3L3, CXCR4,
TMSB4X, and PI3). For example, we found that CCL3, CCL3L3, and IL8
are highly upregulated throughout the ﬁrst 8 h of Ap infection. CCL3
transcripts were conﬁrmed by QRT-PCR to be increased by more than
50-fold after 3 h Ap infection (Table 5). CXCR4 is the receptor for
CXCL12/SDF-1α and a member of the G-protein-coupled receptor
superfamily, which mediates ERK pathway activation [25–27]. CXCR4
was upregulated threefold at 3 h and sixfold at 8 h (Table 1). Kremer et
al. have shown that SDF-1α signaling via CXCR4 in T lymphocytes
utilizes both the tyrosine kinase ZAP-70 and the scaffold molecule
LCP2 (SLP-76) to stimulate prolonged ERK activation in T cells [25].
Interestingly, LCP2 (SLP-76) was highly upregulated in Ap-infected
neutrophils (Table 1) and ERK2 was activated after 3 h of Ap infection
(Fig. 1). These novel ﬁndings were not reported in previous studies
[20,24,28]. The detection of upregulation in our studies may be related
to factors such as the array technology utilized, the use of fresh
primary neutrophil preparations, and the synchronicity and efﬁciency
of infection.
We found a much higher degree of upregulation of expression of
BCL2A1, SOD2, PLAU, and TNFAIP6 genes from 3 to 8 h (Table 1).
Upregulation of BCL2A1, SOD2, and PLAU was conﬁrmed by QRT-PCR,
both previously [19] and in the present study (Table 5). For the
intrinsic pathway, BCL2A1, as an antiapoptotic gene, is highly
upregulated (conﬁrmed and quantitated by RT-PCR) by Ap infection
[19]. Since the function of BCL2A1 in antiapoptotic pathways has been
well studied, we opted to knock down the expression of the BCL2A1
gene in neutrophils, to validate functionally the antiapoptotic effect of
BCL2A1 by Ap infection. An antisense transfection technique was used
to deliver antisense RNA into the neutrophils to block the expression
of BCL2A1. After knockdown, real-time RT-PCRwas performed and the
expression level of BCL2A1 was conﬁrmed to decrease by at least 50%,
compared with wild-type neutrophils (data not shown). By knock-
down of the BCL2A1 gene, we expected to see restoration of apoptosis
in neutrophils. However, there was no signiﬁcant difference in the
timing of apoptosis between BCL2A1 knockdown and wild-type
neutrophils after Ap infection. Similar ﬁndings were observed in a
repeat experiment using different-donor-derived neutrophils (results
not shown). Since Ap infection causes global induction of antiapop-
tosis in human neutrophils, both extrinsic and intrinsic pathways of
apoptosis are affected [19]. This global apoptosis triggers multiple
signaling pathways that orchestrate a complex cascade of events
resulting in an antiapoptotic state and the survival of neutrophils.
Knocking down only one of numerous genes may not be sufﬁcient to
block the antiapoptotic activities induced by Ap infection.
PLAU is a potent plasminogen activator possessing chymotrypsin,
trypsin, u-plasminogen activator, and hydrolase activities. It breaks
down ﬁbrin and degrades extracellular matrix and may be involved in
neutrophil chemotaxis, signal transduction, blood coagulation, and
cell growth and maintenance [29,30]. PLAU is also a chemotactic
factor for neutrophils in vivo [31]; thus, Ap-induced expression of
PLAU may contribute to Ap cell–cell infection of neutrophils and to
the induction of pathogenic changes in affected tissues [32]. In
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shown to be associated with extracellular matrix remodeling, was
increased 17-fold 8 h after Ap infection [33]. On the other hand, PLAU
potentiates LPS-induced neutrophil activation and increases activa-
tion of intracellular signaling pathways, including Akt and c-Jun
N-terminal kinase, NF-κB, and expression of proinﬂammatory
cytokines, including IL-1β, macrophage-inﬂammatory protein-2,
and TNF-α [34]. Generation of superoxide and degranulation of
azurophilic granules were signiﬁcantly diminished in neutrophils
obtained from PLAU-deﬁcient mice, indicating that antimicrobial
activation in vitro was compromised [35]. Therefore, upregulation of
PLAU may play a role in neutrophil activation for bacterial killing and
effective innate host defense.
The antiapoptotic IER3 gene is an ERK substrate that has a dual role
in ERK signaling by acting both as an ERK downstream effector
mediating survival and as a regulator of ERK activation [36]. This gene
functions in the protection of cells from Fas- or tumor necrosis factor-
α-induced apoptosis [37]. Yeast two-hybrid studies showed its
interaction with MCL1, a major antiapoptotic gene in neutrophils
[38]. PI3 (SKALP) encodes an elastase-speciﬁc inhibitor, which
contains a WAP-type four-disulﬁde core (WFDC) domain and is thus
a member of the WFDC domain family [39]. It is upregulated 11- and
24-fold after 3 and 8 h of Ap infection, respectively (Table 1).
Upregulation of this potent inhibitor may protect Ap from the killing
effect of the neutrophil-speciﬁc elastase [40,41]. Interestingly,
NOTCH2NL, which also interacts with neutrophil elastase [42], is
upregulated 3-fold at both 3 and 8 h Ap infection, though its protective
function is not known. TMSB4X, MARCKS, ACTB, and PFN1 are genes
involved in actin polymerization [43–46]. TMSB4X encodes an actin-
sequestering protein that plays a role in both regulation of actin
polymerization and antiapoptosis [47,48]. Modiﬁcation of the actin
cytoskeleton by Ap may be important in intracellular infection [49].
Interestingly, CD83, a dendritic cell (DC) maturation marker, was
signiﬁcantly upregulated (9-fold by microarray and 60-fold by QRT-
PCR) 3 h after Ap infection (Tables 1 and 5). Since acquisition of CD83
provides functional characteristics of DCs to neutrophils, which may
then activate T cell responses [50,51], it is possible that Ap may affect
host responses important in disease pathogenesis and/or bacterial
clearance through CD83 [52]. Another highly upregulated gene of
interest is ZC3H12A (Tables 1 and 5). ZC3H12A, previously known as
FLJ23231, and also upregulated in Ap-infected HL-60 cells (Table 2), is
a novel monocyte chemoattractant protein-1-induced transcription
factor that causes cell death in cardiac myocytes and human
embryonic kidney 293 cells [53].
Alteration of HL-60 gene expression induced by Ap infection
Ap infection alters HL-60 cell gene expression but to a lesser extent
compared to that of neutrophils (Tables 2 and 4). Although diverse
patterns of gene expression were observed at various time points
postinfection, the genes altered in response to Ap infection can be
divided into two general groups in terms of the pattern of the
response to infection. Those in group 1 were upregulated early after
Ap infection, typically within 2 h, and this induction was transient.
Expression levels decreased to normal ranges at a later time point
(22 h). Genes in this group included cytokines and chemokines (IL1β,
CCL3, CCL3L3, CCL4, and IL8) and genes related to the NF-κB signaling
pathway, the Toll-like receptor signaling pathway, and cytokine–
cytokine receptor interactions and apoptosis (NFKBIA, TNFAIP3, TNF,
IL1β, IL8, CCL4, CCL14, and TNF) (Table 2). The highest degree of
upregulation was seen with IL1β (6.3-fold) after 2 h Ap infection
(Table 2).
In contrast, a second set of genes was upregulated later, after 8 h
postinfection. The upregulated genes in this group included NCF1, C3,
LGALS1, CD48, and CCND3 (Table 2S). At 22 h, upregulated genes were
found among diverse pathways, including genes related to both focaladhesion (CCND3, GRB2, and ACTC1) and cell movement signaling
(ARPC1B) (Table 2S). The two most upregulated genes at 22 h, NCF1
and C3 (four- and threefold, respectively), are involved in important
defense mechanisms directed against bacterial infection (Table 4).
NCF1 encodes a 47-kDa cytosolic subunit of neutrophil NADPH
oxidase. This oxidase is a multicomponent enzyme that is activated
to produce superoxide anion. Mutations in NCF1 have been associated
with chronic granulomatous disease. Complement component C3
plays a central role in the activation of the complement system. Its
activation is required for both classical and alternative complement
activation pathways. LGALS1 (galectin 1), upregulated at 22 h, belongs
to a family of β-galactoside-binding proteins implicated inmodulating
cell–cell and cell–matrix interactions (Table 4). LGALS1 may act as an
autocrine negative growth factor that regulates cell proliferation.
Interestingly, LGALS1 is also upregulated in Ap-infected human
microvascular endothelial cells (HMEC-1) (unpublished data).
Interestingly, the dendritic cell maturation marker CD83, upregu-
lated in human neutrophil by Ap infection, was also upregulated
throughout the 22-h time course studied in HL-60 cells. Several
important genes found to be upregulated in neutrophils in response to
Ap infection, such as CCL3, CCL3L3, IL8, IL1β, and NFKBIA, were also
upregulated in Ap-infected HL-60 cells. Although these genes are
upregulated in both Ap-infected neutrophil and HL-60 cells, the
overall gene expression proﬁles observed in the two cell types differ
signiﬁcantly.
Comparison with other gene expression studies of Ap-infected cells
Borjession et al. and Sukumaran et al. studied gene expression in
neutrophils following Ap infection [21,24]. Similar studies have also
been performed using the HL-60 and NB4 promyelocytic cell lines
[22,23]. Combining the data from these studies presents an opportu-
nity to elucidate common genes induced by Ap infection in host cells,
although there are differences in bacterial inocula, efﬁciency of
infection, and the postinfection time points in these experiments as
well as in the array platforms and statistical methodologies used. We
focused on the early transcriptional response of neutrophils to Ap
infection. In the study of Sukumaran et al., of the 244 genes altered in
expression, 177 were upregulated and 67 were downregulated at 4 h
postinfection [24]. Borjession et al. observed that 51 genes were
upregulated and 61 were downregulated at 3 h postinfection [21].
However, there were only 9 differentially expressed genes in common
in the two studies at the early time points, even though both groups
utilized the same Affymetrix humanU133 array platform. In our study,
of 112 genes altered in expression at 3 h postinfection, 96 genes were
upregulated and 16 were downregulated, a general pattern similar to
that noted by Sukumaran et al. Our results from the early response
time point (3 h), using long oligonucleotide arrays, and those obtained
by Sukumaran et al. (4 h) yielded 30 differentially expressed genes in
common (genes marked by asterisks in Table 1). Among the
differentially expressed genes in common found in our study and in
Sukumaran et al. [24], upregulated genes dominated in the categories
of apoptosis and cell fate, cytokines/chemokines and their receptors,
cell adhesion and cytoskeleton, and signal molecules, such as BCL2A1,
SOD2, NFKBIA, CCL3, IL8, IL1β, and PLAU. In addition, 2 downregulated
genes, FRAT1 and IL8RB, were identiﬁed both in our study and in that
by Sukumaran et al. [24]. Downregulation of IL8RB (CXCR2) was
conﬁrmed by QRT-PCR (Table 5). This receptor mediates neutrophil
migration to the site of inﬂammation and its downregulation has also
been observed in Helicobacter pylori-infected neutrophils [54].
In addition to expression changes noted by other investigators, we
identiﬁed a number of previously undescribed additional genes that
are upregulated as part of the early transcriptional response to Ap
infection and likely to be important in the molecular pathogenesis of
infection. These include, for example, both CCL3L3 and CXCR4, the
antiapoptotic IER3 gene, the immune-responsive PI3 (SKALP), the cell-
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3 h after Ap infection (Table 1).
Other studies have reported response to Ap infection of the HL-60
and NB4 cell lines. In those studies, de la Fuente et al. used long-oligo
(70-mer) arrays to study the gene expression proﬁle of HL-60 cells 3
days after Ap infection [22]. A report from Pedra et al., using an
Affymetrix human U133 platform, focused on the transcriptional
response of NB4 cells 4 h post-Ap infection. Among those genes
altered in expression in response to Ap infection, only three were
identiﬁed in common in two cell lines, HL-60 in de la Fuente et al. [22]
and NB4 in Pedra et al. [23]. Some differentially expressed genes, such
as IL8 and IL1β, which show early transcriptional responses to Ap
infection in both neutrophils and HL-60 cells, were identiﬁed in the
present study and by Sukumaran et al. [24]. However, neither of these
two genes was detected in either HL-60 cells, after infection for 3 days,
in de la Fuente et al. [22] or NB4 cells in the Pedra et al. study [23]. A
comparison of the gene expression proﬁles of Ap-infected neutrophils
in the present study with those of host cells obtained by others
[21–24] identiﬁed signiﬁcant differences. Among the differentially
expressed genes in this study, none of them were in common with
those from HL-60 cell infected for 3 days by de la Fuente et al. [22] or
with those from NB4 cells by infected Pedra et al. [23]. These
differences were probably introduced by different transcriptional
responses of matured neutrophils and different host cells.
Increased phosphorylation of ERK2 (p42) and p38MAPK by Ap infection
We and others have shown that Ap causes global induction of
antiapoptosis through multiple signaling pathways [19,20,55]. Here
we provide direct evidence that in addition to the p38MAPK pathway,
the ERK pathway, particularly ERK2, is activated in Ap-infected
neutrophils. The phosphorylation of p38MAPK was previously
reported [20] and our study conﬁrms previous observations. However,
phosphorylation of ERK was not reported previously. Thus, multiple
pathways are activated and are likely to be required to maintain a
prolonged antiapoptotic state during intracellular Ap infection.
Enhanced understanding of how Ap induces andmaintains neutrophil
antiapoptosis offers the potential ability to manipulate myeloid cell
survival for clinical beneﬁt.
In conclusion, we report and compare the novel transcriptional
response proﬁles of human neutrophils and HL-60 cells at various
time points after Ap infection, elucidating novel pathways of signal
transduction, particularly in Ap-infected neutrophils. In addition, we
also demonstrate that the long-oligonucleotide platform is suitable for
such gene expression analysis and compares favorably with cDNA and
short oligonucleotide platforms [56]. Long oligonucleotide probes not
only complemented previous gene expression array studies [21–24],
but also have identiﬁed additional genes and pathways that are
modulated during Ap infection, providing new insights into delayed
apoptosis, signaling pathways, transcriptional regulation, immune
response, cell adhesion, and host defense.
Materials and methods
Neutrophil isolation and infection
Human peripheral blood neutrophils (polymorphonuclear neutrophils, PMNs)
were isolated from EDTA-anticoagulated blood of normal donors as approved by the
Research Involving Human Subjects Committee, Food and Drug Administration (FDA).
Neutrophils were puriﬁed by Ficoll gradient (Histopaque 1119; Sigma, St. Louis, MO,
USA), washed twice in phosphate-buffered saline (1×PBS; GIBCO, Carlsbad, CA, USA),
resuspended in RPMI 1640medium (GIBCO) supplementedwith 10% fetal bovine serum
(FBS; HyClone, Logan, UT, USA) and 2mM L-glutamine (GIBCO), and enumerated using a
hemacytometer. Purity was N95% by Giemsa staining.
The Ap strain HGE2 was propagated in HL-60 cells as described [2]. High-passage
Ap (130–140 passages in vitro) was used. The passage levels were same for PMNs and
HL-60 cells in each experiment. Heavily Ap-infected (N90%) HL-60 cells (5×107 cells or
5×107 uninfected HL-60 cells for mock infection) were used to prepare cell-free
bacteria [5]. Cell-free Ap and mock-infected preparations were immediately used toinfect neutrophils (2×107 cells) at a high multiplicity of infection (25–50 bacteria/cell).
Both Ap- and mock-infected neutrophils were cultured in RPMI 1640 supplemented
with 10% FBS at 37 °C in 5% CO2. Apoptosis and infection were monitored by Giemsa
staining. HL-60 (2×107 cells) were also infected with cell-free Ap or mock-infected
preparations as described above and cultured in RPMI 1640 supplemented with 10% FBS
at 37 °C in 5% CO2 for 2, 8, or 22 h to evaluate Ap effects on gene expression in HL-60
cells.
Microarray studies
The human microarray chips containing approximately 17,000 oligonucleotides
were produced at the Center for Biologics Evaluation and Research, FDA. Detailed
information regarding array printing, postprint processing, and testing of array quality
is given elsewhere [19,57]. Target preparation, microarray hybridization, image
quantiﬁcation, and data analyses were previously described [19,57,58]. Total RNAs
from Ap-infected and mock-infected neutrophils and HL-60 cells were extracted at 1, 3,
or 8 h postinfection and 2, 8, or 22 h postinfection, respectively, using Trizol (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer's protocol. In brief, total RNA was
reverse-transcribed using amino-allyl-dUTP. cDNAs synthesized from mock-infected
cells were labeled with Cy3 dye, and cDNAs from Ap-infected cells were labeled with
Cy5 dye. Labeled cDNA probes were puriﬁed, denatured, mixed in hybridization buffer,
and placed on the array slides. The slide covered with a coverslip was placed in a
hybridization chamber and hybridized at 65 °C for 16–18 h. After hybridization, array
slides were washed with 2×SSC with 0.1% SDS for 2 min, 1×SSC for 3 min, and ﬁnally
0.2×SSC for 2min at room temperature. Slides were quickly spin-dried before scanning.
Image acquisition and data analysis
After hybridization and washing, arrays were scanned on a GenePix 4000B scanner
(Axon Instruments, Inc., Foster City, CA, USA) with a 10-μm resolution. Scanned raw
images were analyzed and data ﬁles were generated with GenePix Pro 5.1 (Axon)
software.
For data analysis, data ﬁles were uploaded into mAdb (microarray database; Center
for Information Technology (CIT), NIH) and analyzed using the software tools provided
by the CIT, NIH. The advanced ﬁlters that were applied before data analysis fulﬁlled the
following requirements: spot size at least 30 μm,minimum ﬂuorescence intensity of 200
in both Cy3 and Cy5 channels, and the ratio of signal over background at least 2.0 in both
channels. A standard global normalization approach was used for each experiment. All
of the extracted data were normalized using a 50th-percentile (median) normalization
method available through the mAdb. Statistical analyses were performed and a group
comparison t test was used to compare the difference in gene expression betweenmock
and Ap infected samples.
Gene-speciﬁc conﬁrmation of genes by real-time RT-PCR
Selected genes identiﬁed by gene expression proﬁling were conﬁrmed and
quantitated by two-step real-time quantitative RT-PCR using GAPDH as a normalizer.
Relative quantitation was performed with StrataScript reverse transcriptase and
Brilliant SYBR Green QPCR Master Mix on a Stratagene Mx3000P real-time PCR system
(Stratagene, La Jolla, CA, USA). RNA (200 ng) was reverse-transcribed and 1/50 of the
reaction used in SYBR QPCR (95 °C for 10 min and 50 cycles of 95 °C for 30 s, 55 °C for
60 s, 72 °C for 60 s).
Western blotting
Mock- or Ap-infected (1 or 3 h incubation) neutrophils (1.5×107/ml) were washed
once with 10 ml ice-cold 1×PBS containing 1 mM EDTA (pH 8.0) and 1 mM sodium
vanadate. Cell pellets were then lysed at 4 °C with 50 mM Tris–HCl (pH 7.5)/300 mM
NaCl/1% NP-40, containing 1 mM sodium vanadate and proteinase inhibitors (Complete
Mini;(Roche Applied Science, Indianapolis, IN, USA) for 30 min. Equal amounts of cell
lysates (equivalent to 3×106 cells/lane) were boiled and subjected to gel electrophoresis
on a 10% NuPage Bis–Tris gel with a Mes SDS buffer system (Invitrogen). After
electrophoresis, proteins were electrophoretically transferred onto PVDF membranes.
The blotted membrane was blocked with PBS containing 5% skimmed milk at room
temperature for 1 h, and then themembranewas reactedwith anti-phosphorylated ERK,
which recognizes both phosphorylated ERK1 (p44) and ERK2 (p42), and anti-
phosphorylated p38 MAPK polyclonal Ab (Cell Signaling Technology, Beverly, MA,
USA) overnight at 4 °C. Immunoreactive signal was visualized by enhanced chemilumi-
nescence substrate mixture according to the manufacturer's instructions (Amersham,
ArlingtonHeights, IL, USA). After being stripped, themembranewas incubatedwith anti-
ERK or anti-p38 MAPK Abs (Cell Signaling Technology) for detection of total ERK or p38
MAPK, respectively.
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